FindTrial
Sign In

Research on relationship of leukotrienes and bronchopulmonary dysplasia

Research on relationship of leukotrienes and bronchopulmonary dysplasia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORN-16008890
Enrollment
Unknown
Registered
2016-07-23
Start date
2016-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmanary dysplasia

Interventions

2:therapy of Montelukast

Sponsors

First affiliated hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1) Premature infants with birth weight <1500 g; 2) Informed written parental consent was required.

Exclusion criteria

Exclusion criteria: 1) Serious congenital malformation (2trisomy 21 syndromecyanotic congenital heart disease,diaphragmatic hernias, etc.); 2) Severe cyanotic type of congenital heart disease (TGA and TOF etc.); 3) Congenital genetic metabolic diseases; 4) Informed written parental consent was not required.

Design outcomes

Primary

MeasureTime frame
death;mean duration of oxygen therapy;—

Countries

China

Contacts

Public ContactChen Xiaoqing

First affiliated hospital of Nanjing Medical University

chenxq2002@foxmail.com+86 13951676702

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026